Prognosis of AKI in malignant diseases with and without sepsis

BMC Anesthesiology

Daniel Patschan¹  Gerhard A Müller¹  David Ellenberger²  Alexander Mertens¹  Malte Heeg¹ 

[1]Department of Nephrology and Rheumatology, University Hospital of Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany

[2]Department of Medical Statistics, University Hospital of Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany

关键词: Mortality;    Malignancies;    Sepsis;    AKI;   

Others  :  816726
DOI  :  10.1186/1471-2253-13-36

 received in 2013-08-05, accepted in 2013-10-14,  发布年份 2013

【 摘 要 】

Background

AKI significantly worsens prognosis of hospitalized patients. This is particularly the case in patients with sepsis. The risk for aquiring sepsis is significantly increased in malignant diseases. Aim of the present retrospective study was to analyze outcomes of tumor patients with sepsis and AKI.

Methods

One-thousand and seventeen patients, treated at the ICU of the Department of Nephrology and Rheumatology of the University Hospital Göttingen from 2009 to 2011 were retrospectively analyzed for mortality, sepsis, AKI, need for renal replacement therapy (dialysis) and malignancies.

Results

AKI occurred significantly more frequent in septic than in non-septic patients and in tumor as oposed to non-tumor patients. Mortaliy rates were higher in the respective latter groups. Mortality increased even further if patients suffered from a malignant disease with sepsis and AKI. Mortality rates peaked if dialysis treatment became mandatory. In non-solid tumors 100% of the patients died if they suffered drom sepsis and AKI. This was not the case in solid malignancies (mortality rate 56%).

Conclusions

We conclude that prognosis of tumor patients with AKI and sepsis is very poor. Mortality increases to almost 70% if diaylsis therapy is initiated. Non-solid tumors are associated with a 100% mortality if sepsis and AKI conincide.

【 授权许可】

   
2013 Heeg et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Feldkamp T, Bienholz A, Kribben A: Acute kidney injury. Dtsch Med Wochenschr 2011, 136:194-197.
• [2]Kribben A, Herget-Rosenthal S, Pietruck F, Philipp T: Acute renal failure–an review. Dtsch Med Wochenschr 2003, 128:1231-1236.
• [3]Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006, 17:1503-1520.
• [4]Singbartl K, Kellum JA: AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int 2012, 81:819-825.
• [5]Murugan R, Kellum JA: Acute kidney injury: what’s the prognosis? Nat Rev Nephrol 2011, 7:209-217.
• [6]Zarjou A, Agarwal A: Sepsis and acute kidney injury. J Am Soc Nephrol 2011, 22:999-1006.
• [7]Ricci Z, Ronco C: Pathogenesis of acute kidney injury during sepsis. Curr Drug Targets 2009, 10:1179-1183.
• [8]Maccariello E, Valente C, Nogueira L, et al.: Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units. Nephrol Dial Transplant 2011, 26:537-543.
• [9]Cruz DN, Ricci Z, Ronco C: Clinical review: RIFLE and AKIN–time for reappraisal. Crit Care 2009, 13:211. BioMed Central Full Text
• [10]Patschan SA, Patschan D, Temme J, et al.: Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD). Crit Care 2011, 15:R94. BioMed Central Full Text
• [11]Marshall JC: Endotoxin in the pathogenesis of sepsis. Contrib Nephrol 2010, 167:1-13.
• [12]Levy MM, Fink MP, Marshall JC, et al.: SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 2001, 2003(29):530-538.
• [13]Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R: Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 2008, 36:S198-S203.
• [14]Uchino S, Kellum JA, Bellomo R, et al.: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818.
• [15]Bagshaw SM, Lapinsky S, Dial S, et al.: Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 2009, 35:871-881.
• [16]Plataki M, Kashani K, Cabello-Garza J, et al.: Predictors of acute kidney injury in septic shock patients: an observational cohort study. Clin J Am Soc Nephrol 2011, 6:1744-1751.
• [17]Cartin-Ceba R, Kashiouris M, Plataki M, Kor DJ, Gajic O, Casey ET: Risk factors for development of acute kidney injury in critically ill patients: a systematic review and meta-analysis of observational studies. Crit Care Res Pract 2012, 2012:691013.
• [18]Salahudeen AK, Doshi SM, Pawar T, Nowshad G, Lahoti A, Shah P: Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center. Clin J Am Soc Nephrol 2013, 8:347-354.
• [19]Bentley W: Towards evidence-based emergency medicine: best BETs from the manchester royal infirmary: BET 3: RIFLE criteria versus acute kidney injury network (AKIN) criteria for prognosis of acute renal failure. Emerg Med J 2011, 28:900-901.
• [20]Liborio AB, Abreu KL, Silva GBJ, et al.: Predicting hospital mortality in critically ill cancer patients according to acute kidney injury severity. Oncology 2011, 80:160-166.
• [21]Minuth AN, Terrell JBJ, Suki WN: Acute renal failure: a study of the course and prognosis of 104 patients and of the role of furosemide. Am J Med Sci 1976, 271:317-324.